We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$4.7B
AUM Growth
-$238M
Cap. Flow
-$118M
Cap. Flow %
-2.51%
Top 10 Hldgs %
27.49%
Holding
1,425
New
528
Increased
233
Reduced
492
Closed
45

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$33.5M
2
AMT icon
American Tower
AMT
+$31.3M
3
EQIX icon
Equinix
EQIX
+$12.7M
4
SBAC icon
SBA Communications
SBAC
+$8.56M
5
LAMR icon
Lamar Advertising Co
LAMR
+$6.7M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$41.1M
2
MSFT icon
Microsoft
MSFT
+$34M
3
AMZN icon
Amazon
AMZN
+$23.1M
4
OUT icon
Outfront Media
OUT
+$17.7M
5
UNIT
Uniti Group
UNIT
+$13.8M

Sector Composition

Rank Sector Weight
1 Technology 21.72%
2 Real Estate 17.45%
3 Consumer Discretionary 10.45%
4 Healthcare 9.89%
5 Communication Services 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOX icon
1126
Box
BOX
$4.36B
$93K ﹤0.01%
+5,369
New +$99.1K
SRPT icon
1127
Sarepta Therapeutics
SRPT
$1.63B
$93K ﹤0.01%
+661
New +$100K
VG
1128
DELISTED
Vonage Holdings Corporation
VG
$93K ﹤0.01%
+9,112
New +$101K
KPTI icon
1129
Karyopharm Therapeutics
KPTI
$161M
$92K ﹤0.01%
+419
New +$102K
GBT
1130
DELISTED
Global Blood Therapeutics, Inc.
GBT
$92K ﹤0.01%
+1,676
New +$107K
CLVS
1131
DELISTED
Clovis Oncology, Inc.
CLVS
$91K ﹤0.01%
+15,551
New +$93K
ESPR
1132
DELISTED
Esperion Therapeutics
ESPR
$90K ﹤0.01%
+2,416
New +$95.7K
RGP icon
1133
Resources Connection
RGP
$136M
$90K ﹤0.01%
7,763
+802
+12% +$9.52K
BLUE
1134
DELISTED
bluebird bio
BLUE
$89K ﹤0.01%
+127
New +$99K
TWOU
1135
DELISTED
2U Inc
TWOU
$89K ﹤0.01%
+88
New +$105K
CCXI
1136
DELISTED
ChemoCentryx, Inc.
CCXI
$89K ﹤0.01%
+1,615
New +$86.9K
NBIX icon
1137
Neurocrine Biosciences
NBIX
$18.4B
$88K ﹤0.01%
+913
New +$106K
IRWD icon
1138
Ironwood Pharmaceuticals
IRWD
$626M
$87K ﹤0.01%
+9,727
New +$96.7K
MPAA icon
1139
Motorcar Parts of America
MPAA
$267M
$87K ﹤0.01%
+5,578
New +$95.6K
IONS icon
1140
Ionis Pharmaceuticals
IONS
$9.14B
$85K ﹤0.01%
+1,801
New +$100K
TBRG
1141
DELISTED
TruBridge
TBRG
$85K ﹤0.01%
3,065
+201
+7% +$5.3K
BCRX icon
1142
BioCryst Pharmaceuticals
BCRX
$2.48B
$84K ﹤0.01%
+24,503
New +$105K
CMTL icon
1143
Comtech Telecommunications
CMTL
$51.5M
$84K ﹤0.01%
5,975
+1,574
+36% +$25.2K
EGHT icon
1144
8x8 Inc
EGHT
$271M
$83K ﹤0.01%
+5,363
New +$86.2K
XNCR icon
1145
Xencor
XNCR
$1.48B
$83K ﹤0.01%
+2,140
New +$74.3K
WES icon
1146
Western Midstream Partners
WES
$19.4B
$81K ﹤0.01%
10,072
+1,502
+18% +$13.5K
AGIO icon
1147
Agios Pharmaceuticals
AGIO
$2.14B
$78K ﹤0.01%
+2,229
New +$97.7K
KOD icon
1148
Kodiak Sciences
KOD
$2.52B
$77K ﹤0.01%
+1,297
New +$65.1K
RYAAY icon
1149
Ryanair
RYAAY
$31.1B
$77K ﹤0.01%
+2,348
New +$73K
VCYT icon
1150
Veracyte
VCYT
$4.44B
$77K ﹤0.01%
+2,380
New +$75.6K

Similar funds

Pacer Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, Pacer Advisors held 1,425 positions worth $4.7B, down 4.8% from $4.94B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Pacer Advisors's Q3 2020 filing shows 528 new, 233 increased, 492 reduced and 45 closed positions. Its largest new stake was iShares MSCI South Korea ETF: 103,528 shares worth $6.76M. The largest sale was Apple, an estimated $41.1M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Real Estate and Consumer Discretionary.

  • Pacer Advisors's largest Q3 2020 buy was iShares MSCI South Korea ETF: 103,528 shares worth $6.76M.
  • Pacer Advisors added most to Crown Castle in Q3 2020, an estimated $33.5M increase.
  • Pacer Advisors's biggest Q3 2020 reduction was Apple, cutting an estimated $41.1M.
  • Pacer Advisors fully exited Dell in Q3 2020, selling an estimated $4.74M.
  • Pacer Advisors's ten largest holdings make up 27% of its $4.7B portfolio in Q3 2020.
  • Pacer Advisors opened 528 new positions and closed 45 in Q3 2020.
  • Pacer Advisors's portfolio value fell 4.8% quarter-over-quarter to $4.7B.

Based on Pacer Advisors's 13F filing for Q3 2020, filed 19 Oct 2020.